IDNA
NYSE
$32.26
ISHARES GENOMICS IMMUNOLOGY AND HEALTHCARE ETF (IDNA)
Net assets
$194M
Inception date
June 11, 2019
Expense ratio
0.47%
Sharpe Ratio
1.64
Price Chart
Valuation
Net assets$194M
P/S8.75
P/B3.79
Profitability
Profit Margin-30.3%
Operating Margin6715.6%
Financial Health
Debt-to-Equity10.4%
Growth & Risk
Revenue 5Y CAGR+22.52%
Dividends 5Y CAGR+20.32%
Beta (5Y)0.86
Sharpe Ratio1.64